Glycogen storage disease due to glucose-6-phosphatase deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Glycogen storage disease due to glucose-6-phosphatase deficiency

Synonyms: G6P deficiency | GSD due to G6P deficiency | GSD type 1 | GSD type I | Glycogen storage disease due to G6P deficiency | Glycogen storage disease type 1 | Glycogen storage disease type I | Glycogenosis type 1 | Glycogenosis type I | Hepatorenal glycogenosis | Von Gierke disease

A rare inherited metabolic disease (comprising two major subtypes: type Ia and Ib) characterized by poor tolerance to fasting growth delay and hepatomegaly resulting from accumulation of glycogen and fat in the liver.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Glycogen storage disease due to glucose-6-phosphatase deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

association for glycogen storage disease

The Association for Glycogen Storage Disease (AGSD) is a patient advocacy organization dedicated to protecting and promoting the best interest of all persons affected by the glycogen storage disease. • AGSD is committed to the identification, treatment, and cure of glycogen storage disease through programs of education, advocacy, research, and patient services.

Clinical Trials

For a list of clinical trials in this disease area, please click here.